Alan Shaw, Ph.D., President and CEO, Vedantra
Aleš Štrancar, Ph.D., CEO, BIA Separations
Alex Flood, Ph.D., Program Officer, Technology Solutions, PATH
Aliasger K. Salem, Ph.D., Leader, Cancer Signalling and Experimental Therapeutics, Holden Comprehensive Cancer Center, Pharmaceutical Sciences and Experimental Therapeutics, Chemical and Biochemical Engineering and Biomedical Engineering, College of Pharmacy and Engineering, University of Iowa
Dan H. Barouch, M.D., Ph.D., Associate Professor, Medicine, Chief, Division of Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center
David A. Zarling, Ph.D., Co-Founder, President and CEO, Colby Pharmaceutical Company
Evelyn A. Kurt-Jones, Ph.D., Professor of Medicine, University of Massachusetts Medical School
Geoffrey Stone, Ph.D., Assistant Professor, Microbiology, and Group Leader, Immunology, HIV Immunotherapy Program, University of Miami Miller School of Medicine
Gerald Pier, Ph.D., Professor, Medicine, Microbiology and Immunobiology, Harvard Medical School
Graham J. Clarke, CEO & Director, ImmunoBiology, Ltd
Harriet Robinson, Ph.D., CSO, GeoVax Labs, Inc
Jeffrey Gardner, CEO, Executive, Adjuvance Technologies, Inc.
Joe Cohen, Ph.D., Founder & Director, Cohen Biopharm Consulting
John P. Hennessey, Jr., Ph.D., Vice President, Novadigm Therapeutics, Inc.
John Tsang, Ph.D., Chief, Systems Genomics and Bioinformatics Unit, LSB, Head, Computational Systems Biology, Trans-NIH Center for Human Immunology (CHI), NIAID-NIH
Jon Heinrichs, Ph.D., Director, Microbial Vaccines, Vaccines Research, Merck & Co., Inc.
Karl-Josef Kallen, M.D., Ph.D., CSO, CureVac GmbH
Kate Rittenhouse-Olson, Ph.D., Professor and Director, Biotechnology Program, Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo
Kevin P. Killeen, Ph.D., CSO, Matrivax Research & Development Corp.
Magdalena Tary-Lehmann, M.D., Ph.D., CSO, Cellular Technology Limited (C.T.L.)
Manon Cox, Ph.D., CEO, Protein Sciences
Marc Gurwith, M.D., CMO, PaxVax
Michael T. Osterholm, Ph.D., MPH, Director, Center for Infectious Disease Research and Policy (CIDRAP), Professor, Environmental Health Sciences, School of Public Health, University of Minnesota
Nathalie Garçon, Ph.D., Vice President and Head, Global Center for Adjuvants and Technology Innovation, GlaxoSmithKline Biologicals
Nikolai Petrovsky, Ph.D., Professor, Endocrinology Department, Flinders Medical Centre, Flinders University, and Research Director, Vaxine Pty Ltd.
Peter Palese, Ph.D., Horace W. Goldsmith Professor and Chair, Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai
Petr Ilyinskii, Ph.D., Senior Staff Scientist, Selecta Biosciences, Inc.
Randall Engler, Director, Strategic Accounts, Sales, Novozymes Biopharma US
Ruth M. Ruprecht, M.D., Ph.D., Professor of Medicine, Harvard Medical School and the Dana-Farber Cancer Institute
Shan Lu, M.D., Ph.D., Professor, Infectious Diseases and Immunology, University of Massachusetts Medical School
Theodore Tsai, M.D., Senior Vice President, Scientific Affairs, Novartis Vaccines
Thomas Dubensky, Ph.D., CSO, Research and Development, AduroBioTech, Inc.
Wei Kong, Ph.D., Research Assistant Professor, Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University
William M. Egan, Ph.D., Senior Tech Expert, Novartis Vaccines & Diagnostics, Inc.